Page last updated: 2024-08-24

tirofiban and Hyperlipemia

tirofiban has been researched along with Hyperlipemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cam, N; Okmen, E; Ozen, E; Sanli, A; Tartan, Z; Uyarel, H	1

Trials

1 trial(s) available for tirofiban and Hyperlipemia

Article	Year
Effects of enoxaparin and nadroparin on major cardiac events in high-risk unstable angina treated with a glycoprotein IIb/IIIa inhibitor. Japanese heart journal, 2003, Volume: 44, Issue:6 Topics: Aged; Angina, Unstable; Anticoagulants; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Nadroparin; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk; Tirofiban; Treatment Outcome; Tyrosine	2003

Article

Year

Effects of enoxaparin and nadroparin on major cardiac events in high-risk unstable angina treated with a glycoprotein IIb/IIIa inhibitor.

Japanese heart journal, 2003, Volume: 44, Issue:6

Topics: Aged; Angina, Unstable; Anticoagulants; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Nadroparin; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk; Tirofiban; Treatment Outcome; Tyrosine

2003